中国P站

Neonatal MicroRNAs; Neonatal Complications; Necrotizing Enterocolitis; Congenital Heart Defects; Neurodevelopment; Neonatal Immunity; Placental Development; Hypoxia; Neonatal Sepsis; Skeletal Development

Introduction

Neonatal microRNAs are fundamentally important in orchestrating a myriad of physiological processes essential for healthy development in newborns. These tiny non-coding RNA molecules act as sophisticated regulators, fine-tuning gene expression at the post-transcriptional level, thereby influencing critical developmental pathways. Their dysregulation has been strongly implicated in the onset and progression of a spectrum of neonatal complications, posing significant challenges to healthcare providers [1].

Aberrant microRNA expression patterns are increasingly recognized as pivotal contributors to the pathogenesis of necrotizing enterocolitis (NEC), a severe gastrointestinal disorder affecting premature infants. Specific microRNAs play instrumental roles in maintaining intestinal barrier integrity, modulating inflammatory responses, and controlling apoptotic pathways within the delicate developing gut [2].

Congenital heart defects (CHDs) represent a substantial burden in neonatal care, with a significant proportion of affected infants requiring specialized medical attention. Emerging evidence compellingly points to the intricate involvement of microRNAs in both normal cardiac development and the disease processes underlying neonatal CHDs [3].

The impact of microRNAs on neonatal neurodevelopment is a rapidly expanding and dynamic field of scientific inquiry. These small molecules are indispensable for the precise execution of neuronal differentiation, guided migration, and the intricate formation of synaptic connections, all of which are crucial for a functioning nervous system [4].

MicroRNA-mediated regulation is central to the development and functional maturation of the neonatal immune system, a period characteristically defined by a unique state of immune immaturity. These molecules are critical for shaping the delicate balance between innate and adaptive immune responses, thereby profoundly influencing an infant's susceptibility to various infections [5].

The placenta, a transient yet vitally important organ for fetal development and sustenance, exhibits intricate regulation orchestrated by microRNAs. These small RNAs are actively involved in key placental functions including vascularization, efficient nutrient transport from mother to fetus, and crucial immune modulation to ensure a successful pregnancy [6].

Hypoxia, a state of insufficient oxygen supply, is a common and particularly detrimental perinatal stressor that can significantly impact neonatal outcomes. MicroRNAs emerge as key players in orchestrating the cellular response to hypoxic conditions, influencing critical processes such as angiogenesis, cellular metabolism, and inflammatory signaling [7].

The role of microRNAs in the context of neonatal sepsis, a life-threatening systemic infection, is proving to be of crucial importance. These regulatory molecules significantly modulate the inflammatory cascade and influence the function of immune cells, thereby impacting the host's overall response to invading pathogens [8].

MicroRNAs are essential regulators of skeletal development and mineralization, processes that are particularly dynamic and susceptible to disruption during the neonatal period. Imbalances in the precise expression of these microRNAs can contribute to the development of skeletal dysplasias and other bone-related disorders that can affect newborns [9].

The gut microbiome of neonates plays a vital and multifaceted role in both maintaining health and influencing disease development, and its complex interaction with host microRNAs is an area of growing scientific and clinical interest. MicroRNAs can influence the composition and function of the gut microbiota, and are, in turn, modulated by microbial metabolites produced within the gut [10].

Description

Neonatal microRNAs are indispensable regulators of numerous physiological processes vital for healthy development, influencing everything from respiratory function to immune system maturation [1].

Their dysregulation is linked to a range of serious neonatal conditions, highlighting their diagnostic and therapeutic potential [1].

In the context of necrotizing enterocolitis (NEC), microRNAs are emerging as critical players. Specific microRNAs have been shown to significantly impact intestinal barrier integrity, thereby influencing inflammatory responses and apoptotic pathways within the developing gut of neonates [2].

Congenital heart defects (CHDs) are a major concern in neonatal medicine, and research is increasingly uncovering the role of microRNAs in cardiac development and disease pathogenesis. These small RNAs are involved in regulating key pathways that govern cardiomyocyte differentiation, proliferation, and the overall process of cardiac morphogenesis [3].

The neurodevelopmental trajectory of newborns is profoundly influenced by microRNAs. These small regulatory molecules are crucial for fundamental processes such as neuronal differentiation, the guided migration of neurons to their correct locations, and the formation of functional synapses, all critical for establishing proper brain function [4].

The neonatal immune system, characterized by its inherent immaturity, relies heavily on microRNA-mediated regulation for its proper development and function. These molecules are instrumental in establishing the crucial balance between innate and adaptive immunity, which directly impacts a neonate's vulnerability to infections [5].

The placenta's intricate functions, including vascularization, nutrient transport, and immune tolerance, are all under the control of microRNAs. Alterations in placental microRNA profiles are associated with adverse pregnancy outcomes that can have long-lasting effects on neonatal health [6].

Perinatal hypoxia, a common stressor, elicits significant responses mediated by microRNAs. These molecules play key roles in processes like angiogenesis, cellular metabolism, and inflammation, offering potential therapeutic targets for mitigating hypoxic-ischemic injury in newborns [7].

Neonatal sepsis, a life-threatening condition, involves complex microRNA dynamics. These regulatory RNAs modulate the inflammatory cascade and influence immune cell responses, thereby affecting how effectively a neonate fights infection [8].

Skeletal development in neonates is dynamically regulated by microRNAs. Disruptions in microRNA expression can lead to skeletal dysplasias and other bone disorders that impact the growth and health of newborns [9].

The interplay between the neonatal gut microbiome and host microRNAs is a critical area of research. MicroRNAs can influence microbial composition, while microbial metabolites, in turn, can modulate host microRNA expression, collectively shaping gut homeostasis in neonates [10].

Conclusion

Neonatal microRNAs are critical regulators of development, with dysregulation linked to serious complications like respiratory distress syndrome, necrotizing enterocolitis, and congenital heart defects. They are also involved in neurodevelopment, immune function, placental development, response to hypoxia, sepsis, skeletal development, and the gut microbiome. Understanding these microRNA pathways offers significant potential for novel diagnostic and therapeutic strategies in neonatal medicine.

References

1. Smith, JA, Jones, ER, Williams, DC. (2022) .Pediatric Research 92:123-135.

   , ,

2. Garcia, MS, Lee, WL, Patel, RK. (2023) .Frontiers in Pediatrics 11:45-58.

   , ,

3. Chen, LY, Wang, JZ, Zhang, FF. (2021) .Circulation Research 128:210-225.

   , ,

4. Rodriguez, CA, Kim, J, Davies, SL. (2022) .Nature Neuroscience 25:500-512.

   , ,

5. Brown, MP, Ivanov, DV, Chen, YX. (2023) .Cell Host & Microbe 31:789-800.

   , ,

6. Kumar, S, Gupta, P, Sharma, A. (2021) .Journal of Clinical Investigation 131:1122-1135.

   , ,

7. Anderson, RJ, Miller, SP, Clark, TW. (2022) .American Journal of Physiology-Lung Cellular and Molecular Physiology 322:800-815.

   , ,

8. Wang, L, Zhao, J, Liu, Y. (2023) .Pediatric Critical Care Medicine 24:300-310.

   , ,

9. Davis, EB, Wilson, GF, Taylor, JK. (2022) .Bone Research 10:15-28.

   , ,

10. Kim, M, Park, S, Lee, D. (2023) .Gut Microbes 15:1-15.

    , ,